Selected article for: "active form and inflammasome complex"
Author: Ribeiro, Sandro Augusto; Lopes, Cassio; Amaral, Ricardo; Amaral, Adilaine
Title: The Therapeutic Potential of Colchicine in the Complications of COVID19. Could the Immunometabolic Properties of an Old and Cheap Drug Help?
  • Cord-id: bcbo5qqs
  • Document date: 2020_7_21
    • ID: bcbo5qqs
    Snippet: The present study analyzes the importance of the inflammasome that involves the NLRP3 complex in the state of hypercytokinemia observed in patients with COVID-19, significantly increasing IL-1β, IL18, IL-6, and TNF. Unfortunately, improving the immune response can sometimes worsen the outcome of the disease. Studies show that colchicine, among other actions, inhibits the assembly of NLRP3 complex that is responsible for generating the active form of Caspase-1 that will convert Pro-IL-1β and Pr
    Document: The present study analyzes the importance of the inflammasome that involves the NLRP3 complex in the state of hypercytokinemia observed in patients with COVID-19, significantly increasing IL-1β, IL18, IL-6, and TNF. Unfortunately, improving the immune response can sometimes worsen the outcome of the disease. Studies show that colchicine, among other actions, inhibits the assembly of NLRP3 complex that is responsible for generating the active form of Caspase-1 that will convert Pro-IL-1β and Pro-IL-18 into their active forms. We suggest using colchicine, a class of drugs with low-cost, extensively tested, well-tolerated medicine as a complementary treatment for patients with COVID-19, in early stages of the disease based on knowledge of its immunomodulatory properties.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute inflammation: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • abdominal pain and acute outbreak: 1, 2, 3, 4, 5, 6, 7
    • abdominal pain and acute phase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • abdominal pain and acute phase protein: 1
    • abdominal pain and add treatment: 1
    • abdominal pain and ade antibody dependent enhancement: 1
    • abdominal pain and liver cirrhosis: 1, 2, 3
    • abdominal pain and loading dose: 1, 2
    • abdominal pain and longitudinal study: 1, 2
    • acute coronary syndrome and loading dose: 1, 2
    • acute coronary syndrome and longitudinal study: 1
    • acute coronary syndrome and macrophage receptor: 1
    • acute inflammation and ade antibody dependent enhancement: 1
    • acute inflammation and adhesion molecule: 1, 2, 3, 4, 5, 6
    • acute inflammation and longitudinal study: 1, 2, 3
    • acute inflammation and macrophage receptor: 1, 2, 3